Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

18th International PhD Student Cancer Conference

Since 2007, the IPSCC has served as a collaborative platform for PhD students from leading cancer research institutes across Europe. The conference covers the full [...]

Go to Top